Related Experiment Video
Updated: Jan 6, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
From numerical amplification to functional metamorphosis: the MDSC-driven therapeutic resistance in tumor
Ruyuan Li1, Anqi Zhao1, Changxiang Yan2
1Department of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Abstract:
Myeloid-derived suppressor cells (MDSCs) are a population with immunosuppressive characteristics in the tumor microenvironment, which are linked to poor prognosis and therapeutic resistance across cancers. In this review, a novel concept of MDSCs and a quantity-quality pattern are proposed to illustrate the spatiotemporal dynamics of MDSC fate. By reviewing current researches through this framework, a group of pro-tumor signals is identified to have critical roles in the whole life cycle of MDSC evolution, including immature myeloid cell proliferation, differentiation education, suppressive functioning of MDSCs, and targeting strategy.
Related Concept Videos
Treatment Resistant Cancers
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

